Last 12 months
Inside the activity.
15 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 3 | 0 |
| Sep 2026 | 4 | 0 |
| Oct 2026 | 3 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 25,000 | Not disclosed Strike: $34.61 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 3 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 25,000 shares Expires 2026-02-24 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 25,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016. In exchange, the reporting person received a replacement option, for 15,625 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,909 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 2 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,909 Underlying: Ordinary Shares · 15,909 shares Expires 2025-03-11 F2 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 17,500 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 15,909 ordinary shares, having an exercise price of $22.85 per ordinary share. F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:42 UTC |
Walker Karin LChief Accounting Officer
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 17,500 | Not disclosed Strike: $27.81 | Not disclosed |
DisclosureSEC source: 0001567619-21-004311 · doc1.xml · derivative · entry 1 Walker Karin L · CIK 0001559422 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 17,500 shares Expires 2025-03-11 F2 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 17,500 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 15,909 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 140,601 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 12 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,601 Underlying: Ordinary Shares · 140,601 shares Expires 2028-02-21 F9 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 187,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 140,601 ordinary shares, having an exercise price of $22.85 per ordinary share. F10 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 187,000 | Not disclosed Strike: $33.10 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 11 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 187,000 shares Expires 2028-02-21 F9 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 187,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 140,601 ordinary shares, having an exercise price of $22.85 per ordinary share. F8 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 62,500 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 10 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Ordinary Shares · 62,500 shares Expires 2027-02-22 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 120,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 62,500 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 120,000 | Not disclosed Strike: $55.00 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 9 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 120,000 shares Expires 2027-02-22 F7 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 120,000 of the issuer's ordinary shares granted to the reporting person on February 22, 2017. In exchange, the reporting person received a replacement option, for 62,500 ordinary shares, having an exercise price of $22.85 per ordinary share. F6 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 22, 2018 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 16,759 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 8 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,759 Underlying: Ordinary Shares · 16,759 shares Expires 2026-11-02 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on November 2, 2016. In exchange, the reporting person received a replacement option, for 16,759 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 30,000 | Not disclosed Strike: $45.13 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 7 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2026-11-02 F5 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 30,000 of the issuer's ordinary shares granted to the reporting person on November 2, 2016. In exchange, the reporting person received a replacement option, for 16,759 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,125 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 6 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,125 Underlying: Ordinary Shares · 25,125 shares Expires 2026-09-01 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on September 1, 2016. In exchange, the reporting person received a replacement option, for 25,125 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 50,000 | Not disclosed Strike: $52.21 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 5 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 50,000 shares Expires 2026-09-01 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 of the issuer's ordinary shares granted to the reporting person on September 1, 2016. In exchange, the reporting person received a replacement option, for 25,125 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,625 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 4 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,625 Underlying: Ordinary Shares · 40,625 shares Expires 2026-02-24 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016. In exchange, the reporting person received a replacement option, for 40,625 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $34.61 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 3 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 65,000 shares Expires 2026-02-24 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on February 24, 2016. In exchange, the reporting person received a replacement option, for 40,625 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 59,090 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 2 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,090 Underlying: Ordinary Shares · 59,090 shares Expires 2025-03-11 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 59,090 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:41 UTC |
Kinney Gene G.Director · President and CEO
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 65,000 | Not disclosed Strike: $27.81 | Not disclosed |
DisclosureSEC source: 0001567619-21-004310 · doc1.xml · derivative · entry 1 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 65,000 shares Expires 2025-03-11 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 65,000 of the issuer's ordinary shares granted to the reporting person on March 11, 2015. In exchange, the reporting person received a replacement option, for 59,090 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 6,315 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 6 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,315 Underlying: Ordinary Shares · 6,315 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $56.23 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 5 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,000 shares Expires 2027-05-18 F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 12,000 of the issuer's ordinary shares granted to the reporting person on May 18, 2017. In exchange, the reporting person received a replacement option, for 6,315 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 8,426 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 4 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,426 Underlying: Ordinary Shares · 8,426 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $42.50 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 3 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-05-20 F3 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 20, 2016. In exchange, the reporting person received a replacement option, for 8,426 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 9,803 | Not disclosed Strike: $22.85 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 2 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,803 Underlying: Ordinary Shares · 9,803 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 23:40 UTC |
Selkoe Dennis J.Director
|
Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 15,000 | Not disclosed Strike: $34.04 | Not disclosed |
DisclosureSEC source: 0001567619-21-004309 · doc1.xml · derivative · entry 1 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2025-05-22 F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 15,000 of the issuer's ordinary shares granted to the reporting person on May 22, 2015. In exchange, the reporting person received a replacement option, for 9,803 ordinary shares, having an exercise price of $22.85 per ordinary share. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:31 UTC |
Kinney Gene G.Director · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $6.41 | $0.00 |
DisclosureSEC source: 0001567619-20-015757 · doc1.xml · derivative · entry 2 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,074 Underlying: Ordinary Shares · 10,000 shares Expires 2023-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| August 17, 2020 Filed Aug 19, 2020 20:31 UTC |
Kinney Gene G.Director · President and CEO
|
Exercise / conversionOrdinary Shares, par value $0.01 per share | 10,000 | $6.41 | $64,100.00 |
DisclosureSEC source: 0001567619-20-015757 · doc1.xml · nonDerivative · entry 1 Kinney Gene G. · CIK 0001564380 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects cash exercise of stock option without the disposition of the underlying shares. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:39 UTC |
COLLIER RICHARD TDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011034 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 16:40 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011035 · doc1.xml · derivative · entry 1 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:37 UTC |
Ekman LarsDirector · Chairman of the Board
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011030 · doc1.xml · derivative · entry 2 Ekman Lars · CIK 0001376117 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:38 UTC |
Cooke ShaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011031 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:42 UTC |
Cobb Paula KDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011041 · doc1.xml · derivative · entry 1 Cobb Paula K · CIK 0001763372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:41 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011039 · doc1.xml · derivative · entry 1 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:40 UTC |
Selkoe Dennis J.Director
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $11.33 | $0.00 |
DisclosureSEC source: 0001567619-20-011037 · doc1.xml · derivative · entry 3 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2030-05-20 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day of the annual general meeting in 2021 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| April 08, 2020 Filed Feb 14, 2025 23:34 UTC |
Nguyen TranChief Strategy Officer and CFO
|
OtherOrdinary Shares, par value $0.01 per share | 995 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000708 · form4.xml · nonDerivative · entry 1 Nguyen Tran · CIK 0001457013 · Chief Strategy Officer and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,205 F1 · kind: Represents shares transferred to the Reporting Person's former spouse in connection with a divorce proceeding. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 23:24 UTC |
Smith Brandon S.Chief Business Officer
|
GrantStock Option (Right to Buy) · Derivative | 240,000 | $0.00 Strike: $11.12 | $0.00 |
DisclosureSEC source: 0001567619-20-005646 · doc1.xml · derivative · entry 1 Smith Brandon S. · CIK 0001805226 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,000 Underlying: Ordinary Shares · 240,000 shares Expires 2030-03-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:17 UTC |
Zago Wagner M.Chief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005019 · doc1.xml · derivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 17:18 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005020 · doc1.xml · derivative · entry 1 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:14 UTC |
Nguyen TranSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 105,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005018 · doc1.xml · derivative · entry 2 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Ordinary Shares · 105,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:13 UTC |
Kinney Gene G.President and CEO
|
GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005017 · doc1.xml · derivative · entry 2 Kinney Gene G. · CIK 0001564380 · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 200,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:20 UTC |
Walker Karin LSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005023 · doc1.xml · derivative · entry 1 Walker Karin L · CIK 0001559422 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:19 UTC |
Malecek Michael JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005022 · doc1.xml · derivative · entry 1 Malecek Michael J · CIK 0001779336 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 25, 2020 Filed Feb 27, 2020 22:19 UTC |
Tripuraneni RadhikaChief Development Officer
|
GrantStock Option (Right to Buy) · Derivative | 70,000 | $0.00 Strike: $12.15 | $0.00 |
DisclosureSEC source: 0001567619-20-005021 · doc1.xml · derivative · entry 1 Tripuraneni Radhika · CIK 0001761114 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Ordinary Shares · 70,000 shares Expires 2030-02-25 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 18:11 UTC |
Cobb Paula KDirector
|
GrantStock Option (Right to Buy) · Derivative | 35,000 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001567619-19-014389 · doc1.xml · derivative · entry 1 Cobb Paula K · CIK 0001763372 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires 2029-07-02 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 33 1/3% of the total number of shares subject to the option on the first anniversary of the grant date, 33 1/3% on the second anniversary of the grant date, and the remaining 33 1/3% on the earlier of the third anniversary of the grant date or the day prior to the annual general meeting in 2022 of the Issuer's shareholders, assuming continuous services as a director until each such vesting date. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 18:10 UTC |
Malecek Michael JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001567619-19-014388 · doc1.xml · derivative · entry 1 Malecek Michael J · CIK 0001779336 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Ordinary Shares · 250,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on July 1, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:08 UTC |
COLLIER RICHARD TDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012075 · doc1.xml · derivative · entry 2 COLLIER RICHARD T · CIK 0001110751 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 16:07 UTC |
HENNEY CHRISTOPHER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012072 · doc1.xml · derivative · entry 1 HENNEY CHRISTOPHER S · CIK 0001242880 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:05 UTC |
Ekman LarsDirector · Chairman of the Board
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012070 · doc1.xml · derivative · entry 2 Ekman Lars · CIK 0001376117 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:09 UTC |
Cooke ShaneDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012077 · doc1.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:07 UTC |
Harfstrand Karl Anders OlofDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012073 · doc1.xml · derivative · entry 1 Harfstrand Karl Anders Olof · CIK 0001646451 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| May 22, 2019 Filed May 24, 2019 20:06 UTC |
Selkoe Dennis J.Director
|
GrantStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $9.23 | $0.00 |
DisclosureSEC source: 0001567619-19-012071 · doc1.xml · derivative · entry 3 Selkoe Dennis J. · CIK 0001582306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Underlying: Ordinary Shares · 17,500 shares Expires 2029-05-22 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual general meeting in 2020 of the Issuer's shareholders, assuming continuous service as a director until such vesting date. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:15 UTC |
Zago Wagner M.Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0000899243-19-005425 · doc4.xml · derivative · entry 1 Zago Wagner M. · CIK 0001708681 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2029-02-27 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 16:15 UTC |
Karp Carol D.Chief Regulatory Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0000899243-19-005426 · doc4.xml · derivative · entry 1 Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2029-02-27 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
| February 27, 2019 Filed Mar 1, 2019 21:15 UTC |
Nguyen TranSee Remarks
|
GrantStock Option (right to buy) · Derivative | 95,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0000899243-19-005427 · doc4.xml · derivative · entry 2 Nguyen Tran · CIK 0001457013 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Ordinary Shares · 95,000 shares Expires 2029-02-27 F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2020 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.